+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Von Willebrand Disease (VWD) Treatment Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 118 Pages
  • May 2023
  • Region: Global
  • Acute Market Reports
  • ID: 5807559
Description Jump to:
Von Willebrand Disease (VWD) Treatment Market is expected to grow at 5.5% by 2031. According to World Federation of Hemophilia (WFH), von Willebrand disease (VWD) is the most common type of bleeding disorder. People with VWD have a problem with a protein in their blood called von Willebrand factor (VWF) that helps control bleeding. When a blood vessel is injured and bleeding occurs, VWF helps cells in the blood, called platelets, mesh together and form a clot to stop the bleeding. According to market experts, around 1% of the world's population suffers from VWD, but due to presence of very mild symptoms only a few number of patients are aware about the condition. Research has shown that as many as 9 out of 10 people with VWD have not been diagnosed. On the basis of type of VWD, von Willebrand disease treatment market can be segmented as Type 1 VWD, Type 2 VWD and Type 3 VWD. The types of therapeutic treatments used against von Willebrand disease are Desmopressin (DDAVP), hormone replacement therapy, contraceptives, anti-fibrinolytic or clot-stabilizing drugs, and fibrin sealants.

Recently, the FDA has approved Bendeka (bendamustine) product of Teva and Eagle Pharmaceuticals, a novel drug formulation that can be administered via a shorter, lower-volume infusion - for chronic lymphocytic leukaemia and B-cell non-Hodgkin's lymphoma.It was observed that Teva received US commercialisation rights to Bendeka under a deal with Eagle signed in February, and plans to launch the therapy during the first quarter of 2016.

The key factor responsible for growth of von Willebrand disease is increasing public awareness related to VWD which is fueling the diagnosis rate in North America and Europe. North America was observed as the largest market for von Willebrand disease treatment followed by Europe. Asia Pacific was anticipated to grow at a fastest CAGR during the forecast period 2016 to 2022. The key factors assisting the growth of Asia Pacific von Willebrand disease treatment market are the rising awareness associated with the rare diseases, developing healthcare infrastructure, high disposable income and government support for novel treatment against rare genetic diseases.

Key Players Identified for von Willebrand disease (VWD) Treatment Market Include but are Not Limited to:

Octapharma AG, Crifols, S.A., Shire plc, Bayer AG, CSL Behring, Pfizer, Inc., Akorn, Inc., Ferring B.V. Other Notable Players.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2022 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation of Von Willebrand Disease (VWD) Treatment market are as follows:
  • Research and development budgets of manufacturers and government spending
  • Revenues of key companies in the market segment
  • Number of end users and consumption volume, price and value.
  • Geographical revenues generate by countries considered in the report
  • Micro and macro environment factors that are currently influencing the Von Willebrand Disease (VWD) Treatment market and their expected impact during the forecast period.
Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Disease Type

  • Type 1 von Willebrand Disease
  • Type 2 von Willebrand Disease
  • Type 3 von Willebrand Disease
  • Acquired von Willebrand Disease

Drug

  • Desmopressin
  • Clot-stabilizing Medications
  • Replacement Therapies
  • Contraceptives
  • Others

Route of Administration

  • Oral
  • Injection
  • Others

Key questions answered in this report

  • What are the key micro and macro environmental factors that are impacting the growth of Von Willebrand Disease (VWD) Treatment market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Von Willebrand Disease (VWD) Treatment market?
  • Which is the largest regional market for Von Willebrand Disease (VWD) Treatment market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Von Willebrand Disease (VWD) Treatment market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Von Willebrand Disease (VWD) Treatment market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Von Willebrand Disease (VWD) Treatment Market
2.2. Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022 (US$ Million)
2.3. Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022 (US$ Million)
2.4. Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022 (US$ Million)
2.5. Global Von Willebrand Disease (VWD) Treatment Market, By Geography, 2022 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2022
3. Von Willebrand Disease (VWD) Treatment Market: Competitive Analysis
3.1. Market Positioning of Key Von Willebrand Disease (VWD) Treatment Market Vendors
3.2. Strategies Adopted by Von Willebrand Disease (VWD) Treatment Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2022 Versus 2031
4. Von Willebrand Disease (VWD) Treatment Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Von Willebrand Disease (VWD) Treatment Market Value, 2021 - 2031, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
5. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2022 Versus 2031
5.3. Market Segmentation
5.3.1. Type 1 von Willebrand Disease
5.3.2. Type 2 von Willebrand Disease
5.3.3. Type 3 von Willebrand Disease
5.3.4. Acquired von Willebrand Disease
6. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2022 Versus 2031
6.3. Market Segmentation
6.3.1. Desmopressin
6.3.2. Clot-stabilizing Medications
6.3.3. Replacement Therapies
6.3.4. Contraceptives
6.3.5. Others
7. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2022 Versus 2031
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Injection
7.3.3. Others
8. North America Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)
8.1. Market Overview
8.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
8.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
8.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
8.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
8.5.1.North America
8.5.1.1. U.S.
8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
8.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
8.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
8.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9. UK and European Union Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)
9.1. Market Overview
9.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
9.5.1.UK and European Union
9.5.1.1. UK
9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9.5.1.5. France
9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
9.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10. Asia Pacific Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)
10.1. Market Overview
10.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
10.5.1.Asia Pacific
10.5.1.1. China
10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10.5.1.3. India
10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.5.1.4.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.5.1.5.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
10.5.1.6.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
11. Latin America Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)
11.1. Market Overview
11.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
11.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
11.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
11.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
11.5.1.Latin America
11.5.1.1. Brazil
11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
11.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
11.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
11.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
12. Middle East and Africa Von Willebrand Disease (VWD) Treatment Market, 2021-2031, USD (Million)
12.1. Market Overview
12.2. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
12.3. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
12.4. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
12.5.Von Willebrand Disease (VWD) Treatment Market: By Region, 2021-2031, USD (Million)
12.5.1.Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
12.5.1.1.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
12.5.1.2.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Disease Type, 2021-2031, USD (Million)
12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Drug, 2021-2031, USD (Million)
12.5.1.3.1. Von Willebrand Disease (VWD) Treatment Market: By Route of Administration, 2021-2031, USD (Million)
13. Company Profile
13.1. Octapharma AG
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. Grifols, S.A.
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Shire plc
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Bayer AG
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. CSL Behring
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Pfizer, Inc.
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. Akorn, Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Ferring B.V.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Other Notable Players
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
List of Figures
Figure. 1 Global Von Willebrand Disease (VWD) Treatment Market: Market Coverage
Figure. 2 Research Methodology and Data Sources
Figure. 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure. 4 Global Von Willebrand Disease (VWD) Treatment Market: Quality Assurance
Figure. 5 Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022
Figure. 6 Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022
Figure. 7 Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022
Figure. 8 Global Von Willebrand Disease (VWD) Treatment Market, By Geography, 2022
Figure. 9 Market Geographical Opportunity Matrix - Global Von Willebrand Disease (VWD) Treatment Market, 2022
Figure. 10 Market Positioning of Key Von Willebrand Disease (VWD) Treatment Market Players, 2022
Figure. 11 Global Von Willebrand Disease (VWD) Treatment Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031
Figure. 12 Global Von Willebrand Disease (VWD) Treatment Market, By Disease Type, 2022 Vs 2031, %
Figure. 13 Global Von Willebrand Disease (VWD) Treatment Market, By Drug, 2022 Vs 2031, %
Figure. 14 Global Von Willebrand Disease (VWD) Treatment Market, By Route of Administration, 2022 Vs 2031, %
Figure. 15 U.S. Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 16 Canada Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 17 Rest of North America Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 18 UK Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 19 Germany Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 20 Spain Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 21 Italy Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 22 France Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 23 Rest of Europe Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 24 China Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 25 Japan Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 26 India Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 27 Australia Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 28 South Korea Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 29 Rest of Asia Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 30 Brazil Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 31 Mexico Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 32 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 33 GCC Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 34 Africa Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
Figure. 35 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market (US$ Million), 2021 - 2031
List of Tables
Table 1 Global Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 2 Global Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 3 Global Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 4 North America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 5 North America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 6 North America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 7 U.S. Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 8 U.S. Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 9 U.S. Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 10 Canada Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 11 Canada Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 12 Canada Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 13 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 14 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 15 Rest of North America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 16 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 17 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 18 UK and European Union Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 19 UK Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 20 UK Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 21 UK Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 22 Germany Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 23 Germany Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 24 Germany Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 25 Spain Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 26 Spain Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 27 Spain Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 28 Italy Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 29 Italy Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 30 Italy Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 31 France Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 32 France Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 33 France Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 34 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 35 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 36 Rest of Europe Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 37 Asia Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 38 Asia Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 39 Asia Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 40 China Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 41 China Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 42 China Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 43 Japan Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 44 Japan Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 45 Japan Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 46 India Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 47 India Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 48 India Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 49 Australia Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 50 Australia Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 51 Australia Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 52 South Korea Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 53 South Korea Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 54 South Korea Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 55 Latin America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 56 Latin America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 57 Latin America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 58 Brazil Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 59 Brazil Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 60 Brazil Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 61 Mexico Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 62 Mexico Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 63 Mexico Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 64 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 65 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 66 Rest of Latin America Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 67 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 68 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 69 Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 70 GCC Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 71 GCC Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 72 GCC Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 73 Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 74 Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 75 Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)
Table 76 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Disease Type, 2021-2031, USD (Million)
Table 77 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Drug, 2021-2031, USD (Million)
Table 78 Rest of Middle East and Africa Von Willebrand Disease (VWD) Treatment Market By Route of Administration, 2021-2031, USD (Million)

Companies Mentioned

  • Octapharma AG
  • Crifols
  • S.A.
  • Shire plc
  • Bayer AG
  • CSL Behring
  • Pfizer Inc.
  • Akorn Inc.
  • Ferring B.V.

Related Topics

Related Reports

Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update - Product Image

Von Willebrand Disease (vWD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update

  • Report
  • 89 Pages
  • Global
From
Global Von Willebrand Disease Treatment Market by Disease Type (Acquired VWD, Type 1, Type 2), Treatment (Clot-Stabilizing, Desmopressin, Replacement Therapies), Route of Administration - Forecast 2024-2030 - Product Image

Global Von Willebrand Disease Treatment Market by Disease Type (Acquired VWD, Type 1, Type 2), Treatment (Clot-Stabilizing, Desmopressin, Replacement Therapies), Route of Administration - Forecast 2024-2030

  • Report
  • 191 Pages
  • Global
From
Von Willebrand's Disease - Pipeline Insight, 2024 - Product Image

Von Willebrand's Disease - Pipeline Insight, 2024

  • Clinical Trials
  • 40 Pages
  • Global
From
Textbook of Von Willebrand Disease. Basic and Clinical Aspects. Edition No. 2 - Product Image

Textbook of Von Willebrand Disease. Basic and Clinical Aspects. Edition No. 2

  • Book
  • 304 Pages
von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032 - Product Image

von Willebrand Disease (vWD) Market Opportunity Assessment, Epidemiology, Disease Management, Clinical Trials, Unmet Needs and Forecast to 2032

  • Report
  • 57 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.